Portable Diagnostic Systems

Portable Diagnostic Systems

Private
Newark, New JerseyHealthcare & Life Scienceshttps://www.portabledx.com/

Last Round

Grant

Sep 1, 2025

Total Funding Raised

$2.9M

Momentum Score

50 /100

Company Overview

Portable Diagnostic Systems is a biotech company that develops a portable, microfluidics-based diagnostic platform for rapid, point-of-care testing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment, Sensors

Business Model

B2G

Customer Profile

Hardware + Subscription, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

drug testing platformpoint-of-care testingmicrofluidicslab-on-a-chipsaliva drug testroadside drug testinglaw enforcement technologyrapid diagnosticsbiosensorforensic toxicologyconsumable cartridgesrazor and blade modelcustom assayAI-driven QC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Portable Diagnostic Systems Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Portable Diagnostic Systems Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2025
DebtFeb 27, 2025
GrantSep 27, 2023
GrantJan 11, 2023
AcceleratorMar 1, 2022

Key People

Founding team and executive leadership

Glennon Simmons

Chief Executive Officer, Founder

Founding Team

Nicolas Vansnick

Chief Technology Officer

Executive Team

Portable Diagnostic Systems Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2026

    Monthly visitors grew 89% MoM, from 976 to 1.8K.

  • Feb 20, 2026

    Grew 33% QoQ from 9 to 12 employees.

Portable Diagnostic Systems Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Portable Diagnostic Systems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Portable Diagnostic Systems's valuation, stock price, and market status.

Firmographic Details

HeadquartersNewark, New Jersey
Employee Range12
Year Founded2019
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.